Package 53041-690-09

{"route": ["ORAL", "RECTAL"], "spl_id": "9cfdb214-1075-4449-9a01-f04cf5d0edfe", "openfda": {"unii": ["3X9MR4N98U", "V5403H8VG7"], "spl_set_id": ["e9da4d3d-d0ca-44f7-aaeb-ae49c3839775"], "manufacturer_name": ["Guardian Drug Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "120 mL in 1 BOTTLE, GLASS (53041-690-03)", "package_ndc": "53041-690-03", "marketing_start_date": "20191218"}, {"sample": false, "description": "30 mL in 1 BOTTLE, GLASS (53041-690-09)", "package_ndc": "53041-690-09", "marketing_start_date": "20191218"}], "brand_name": "Diatrizoate Meglumine and Diatrizoate Sodium", "product_id": "53041-690_9cfdb214-1075-4449-9a01-f04cf5d0edfe", "dosage_form": "SOLUTION", "pharm_class": ["Radiographic Contrast Agent [EPC]", "Radiographic Contrast Agent [EPC]", "X-Ray Contrast Activity [MoA]", "X-Ray Contrast Activity [MoA]"], "product_ndc": "53041-690", "generic_name": "Diatrizoate Meglumine and Diatrizoate Sodium", "labeler_name": "Guardian Drug Company", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Diatrizoate Meglumine and Diatrizoate Sodium", "active_ingredients": [{"name": "DIATRIZOATE MEGLUMINE", "strength": "660 mg/mL"}, {"name": "DIATRIZOATE SODIUM", "strength": "100 mg/mL"}], "application_number": "ANDA214201", "marketing_category": "ANDA", "marketing_start_date": "20191218", "listing_expiration_date": "20261231"}